Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-26 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA from the Harvard Business School. |
| 2019-04-29 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA from the Harvard Business School. |
| 2020-04-28 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA with Distinction from the Harvard Business School. |
| 2021-04-28 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA with Distinction from the Harvard Business School. |
| 2022-04-28 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA with Distinction from the Harvard Business School. |
| 2023-04-28 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an MBA with Distinction from the Harvard Business School. |
| 2024-04-26 | Mr. Middleton holds a B.S. in chemistry from the Massachusetts Institute of Technology and an M.B.A. with Distinction from the Harvard Business School. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-15 | Mr. Middleton has been a General Partner in Sanderling Ventures, was part of Genentech's management team with roles in finance and corporate development, and holds an MBA and a BS in Chemistry. |
| 2011-04-15 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in Chemistry from the Massachusetts Institute of Technology. |
| 2012-06-08 | Fred A. Middleton, a member of our board of directors, is a managing director of the affiliates of Sanderling Venture Partners that participated in the PIPE and which received warrants in connection with the Silicon Valley Bank extension. |
| 2012-07-20 | Mr. Middleton, 63, served as our Chairman of the Board from June 1990 until May 2012. He has been a General Partner in Sanderling Ventures since 1987. Prior to that time, he was an independent investor in the biomedical field. |
| 2013-04-26 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in Chemistry from the Massachusetts Institute of Technology. His business experience provides a unique perspective on the Company’s strategic initiatives, investor markets and financial outlook. |
| 2014-04-28 | Mr. Middleton’s business experience provides a unique perspective on the Company’s strategic initiatives, investor markets and financial outlook. |
| 2015-04-17 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in chemistry from MIT, with experience in venture capital and biotech companies. |
| 2016-04-14 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in chemistry from the Massachusetts Institute of Technology. Mr. Middleton’s business experience provides a unique perspective on the Company’s strategic initiatives, investor markets and financial outlook. |
| 2017-04-13 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in chemistry from the Massachusetts Institute of Technology. |
| 2018-04-12 | Mr. Middleton holds an M.B.A. from Harvard University and a B.S. degree in chemistry from the Massachusetts Institute of Technology. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22